Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 3—March 2012

Lineage-specific Virulence Determinants of Haemophilus influenzae Biogroup aegyptius

Fiona R. Strouts1, Peter Power, Nicholas J. Croucher, Nicola Corton, Andries van Tonder, Michael A. Quail, Paul R. Langford, Michael J. Hudson, Julian Parkhill, J. Simon KrollComments to Author , and Stephen D. Bentley
Author affiliations: Imperial College London, London, UK (F.R. Strouts, P.R. Langford, J.S. Kroll); University of Oxford, Oxford, UK (P. Power); Wellcome Trust Sanger Institute, Cambridge, UK (N.J. Croucher, N. Corton, A. van Tonder, M.A. Quail, J. Parkhill, S.D. Bentley); The Health Protection Agency, Salisbury, UK (M.J. Hudson)

Main Article

Table 3

Phage loci identified in genome of Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius strain F3031*

Phage region Cluster start Size, kb G+C content, % No. genes No. Hae-specific (HaeBPF-specific) genes Closest phage/gene product homologs
1 85,874 32 40.5 35 5 (5) Haemophilus bacteriophage HP1, HP2, S2
2 325,263 47 41.2 60 0 (0) Putative phage-related proteins from H. influenzae, Neisseria meningitidis
3 418,932 33 40.0 38 2 (2) Mu-like phage from H. influenzae, Mannheimia haemolytica
4 857,914 54 39.5 60 5 (3) Putative phage-related proteins from H. influenzae, N. meningitidis
5 1,240,967 30 40.6 26 0 (1) Mu-like phage from H. influenzae, H. somnus, H. parasuis

*Hae, Haemophilus influenzae biogroup aegyptius; BPF, Brazilian purpuric fever.

Main Article

1Current affiliation: Stanford University, Palo Alto, California, USA.

Page created: February 16, 2012
Page updated: February 16, 2012
Page reviewed: February 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.